SEARCH

SEARCH BY CITATION

References

  • Aisen P. S. and Davis K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry 151, 11051113.
  • Anton R. F., Wallis C. and Randall C. L. (1983) In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 26, 421429.
  • Atsumi G., Murakami M., Tajima M., Shimbara S., Hara N. and Kudo I. (1997) The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim. Biophys. Acta 1349, 4354.
  • Balsinde J., Winstead M. V. and Dennis E. A. (2002) Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett. 531, 26.
  • Bankers-Fulbright J. L., Kalli K. R. and McKean D. J. (1996) Interleukin-1 signal transduction. Life Sci. 59, 6183.
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Breckenridge W. C. and Kuksis A. (1968) Specific distribution of short-chain fatty acids in molecular distillates of bovine milk fat. J. Lipid Res. 9, 388393.
  • Capriotti A. M., Furth E. E., Arrasmith M. E. and Laposata M. (1988) Arachidonate released upon agonist stimulation preferentially originates from arachidonate most recently incorporated into nuclear membrane phospholipids. J. Biol. Chem. 263, 1002910034.
  • Chilton F. H., Fonteh A. N., Surette M. E., Triggiani M. and Winkler J. D. (1996) Control of arachidonate levels within inflammatory cells. Biochim. Biophys. Acta 1299, 115.
  • Chung I. Y. and Benveniste E. N. (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1β. J. Immunol. 144, 29993007.
  • Clark J. D., Schievella A. R., Nalefski E. A. and Lin L. L. (1995) Cytosolic phospholipase A2. J. Lipid Med. Cell Signal 12, 83117.
  • Contreras M. A., Chang M. C., Rosenberger T. A., Greiner R. S., Myers C. S., Salem N. Jr and Rapoport S. I. (2001) Chronic nutritional deprivation of n-3 α-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. J. Neuro-chem. 79, 10901099.
  • Dennis E. A. (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269, 1305713060.
  • Deutsch J., Grange E., Rapoport S. I. and Purdon A. D. (1994) Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. Anal. Biochem. 220, 321323.
  • Dugas N., Lacroix C., Kilchherr E., Delfraissy J. F. and Tardieu M. (2001) Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine 15, 96107.
  • Farooqui A. A., Liss L. and Horrocks L. A. (1990) Increased activities of lipolytic enzymes in Alzheimer's disease. Adv. Neurol. 51, 127129.
  • Farooqui A. A., Rapoport S. I. and Horrocks L. A. (1997) Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurochem. Res. 22, 523527.
  • Farooqui A. A., Litsky M. L., Farooqui T. and Horrocks L. A. (1999) Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49, 139153.
  • Fitzpatrick F. A. and Soberman R. (2001) Regulated formation of eicosanoids. J. Clin. Invest. 107, 13471351.
  • Folch J., Lees M. and Sloane-Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissue. J. Biol. Chem. 226, 497509.
  • Gattaz W. F., Maras A., Cairns N. J., Levy R. and Forstl H. (1995) Decreased phospholipase A2 activity in Alzheimer brains. Biol. Psychiatry 37, 1317.
  • Gershfeld N. L. and Ginsberg L. (1995) Membrane bilayer instability as a pathogenetic mechanism for neurological disease. Rev. Neurosci. 6, 113.
  • Ghirnikar R. S., Lee Y. L., He T. R. and Eng L. F. (1996) Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 46, 727733.
  • Ginsberg L., Rafique S., Xuereb J. H., Rapoport S. I. and Gershfeld N. L. (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698, 223226.
  • Grange E., Deutsch J., Smith Q. R., Chang M., Rapoport S. I. and Purdon A. D. (1995) Specific activity of brain palmitoyl-CoA pool provides rates of incorporation of palmitate in brain phospholipids in awake rats. J. Neurochem. 65, 22902298.
  • Gronich J., Konieczkowski M., Gelb M. H., Nemenoff R. A. and Sedor J. R. (1994) Interleukin 1α causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 93, 12241233.
  • Guan Z., Wang Y., Cairns N. J., Lantos P. L., Dallner G. and Sindelar P. J. (1999) Decrease and structural modifications of phosphatidyl-ethanolamine plasmalogen in the brain with Alzheimer's disease. J. Neuropathol. Exp. Neurol. 58, 740747.
  • Han X., Holtzman D. M. and McKeel D. W. Jr (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 11681180.
  • Hao C., Guilbert L. J. and Fedoroff S. (1990) Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J. Neurosci. Res. 27, 314323.
  • Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D. and Wenk G. L. (1998a) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780, 294303.
  • Hauss-Wegrzyniak B., Lukovic L., Bigaud M. and Stoeckel M. E. (1998b) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohisto-chemical study. Brain Res. 794, 211224.
  • Hauss-Wegrzyniak B., Vraniak P. and Wenk G. L. (1999) The effects of a novel NSAID on chronic neuroinflammation are age-dependent. Neurobiol. Aging 20, 305313.
  • in ‘T Veld B. A., Launer L. J., Hoes A. W., Ott A., Hofman A., Breteler M. M. and Stricker B. H. (1998) NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol. Aging 19, 607611.
  • in ‘T Veld B. A., Ruitenberg A., Hofman A., Launer L. J., Van Duijn C. M., Stijnen T., Breteler M. M. and Stricker B. H. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 15151521.
  • Jolly C. A., Hubbell T., Behnke W. D. and Schroeder F. (1997) Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch. Biochem. Biophys. 341, 112121.
  • Katsuki H. and Okuda S. (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46, 607636.
  • Kaufmann W. E., Worley P. F., Pegg J., Bremer M. and Isakson P. (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl Acad. Sci. USA 93, 23172321.
  • Kramer R. M. and Sharp J. D. (1997) Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410, 4953.
  • Kuwata H., Nakatani Y., Murakami M. and Kudo I. (1998) Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273, 17331740.
  • Laposata M., Reich E. L. and Majerus P. W. (1985) Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. J. Biol. Chem. 260, 1101611020.
  • Lee S. C., Liu W., Dickson D. W., Brosnan C. F. and Berman J. W. (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β. J. Immunol. 150, 26592667.
  • Leker R. R. and Shohami E. (2002) Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 39, 5573.
  • Murphy E. J., Stephens R., Jurkowitz-Alexander M. and Horrocks L. A. (1993) Acidic hydrolysis of plasmalogens followed by high-performance liquid chromatography. Lipids 28, 565568.
  • Neufeld E. J., Majerus P. W., Krueger C. M. and Saffitz J. E. (1985) Uptake and subcellular distribution of [3H]arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography. J. Cell Biol. 101, 573581.
  • Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H. and Wurtman R. J. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl Acad. Sci. USA 89, 16711675.
  • Owens T. (2002) Identification of new therapeutic targets for prevention of CNS inflammation. Expert Opin. Ther. Targets 6, 203215.
  • Ozaki M., Morii H., Qvist R. and Watanabe Y. (1994) Interleukin-1 beta induces cytosolic phospholipase A2 gene in rats C6 glioma cell line. Biochem. Biophys. Res. Commum. 205, 1217.
  • Pettegrew J. W., Klunk W. E., Kanal E., Panchalingam K. and McClure R. J. (1995) Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol. Aging 16, 973975.
  • Popovich P. G. (2000) Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog. Brain Res. 128, 4358.
  • Powell W. S. (1985) Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases. Anal. Biochem. 148, 5969.
  • Purdon A. D., Rosenberger T. A., Shetty H. U. and Rapoport S. I. (2002) Energy consumption by phospholipid metabolism in mammalian brain. Neurochem. Res. 12, 16411647.
  • Quan N., Sundar S. K. and Weiss J. M. (1994) Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49, 125134.
  • Radin N. S. (1981) Extraction of tissue lipids with a solvent of low toxicity. Meth Enzymol. 72, 57.
  • Rapoport S. I. (2001) In vivo fatty acid incorporation into brain phos-pholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16, 243261.
  • Reynolds L. J., Hughes L. L., Yu, L. and Dennis E. A. (1994) 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal. Biochem. 217, 2532.
  • Rintala J., Seemann R., Chandrasekaran K., Rosenberger T. A., Chang L., Contreras M. A., Rapoport S. I. and Chang M. C. (1999) 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport 10, 38873890.
  • Robinson P. J., Noronha J., DeGeorge J. J., Freed L. M., Nariai T. and Rapoport S. I. (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17, 187214.
  • Rosenberger T. A., Oki J., Purdon A. D., Rapoport S. I. and Murphy E. J. (2002) Rapid synthesis and turnover of brain microsomal ether phospholipids in the adult rat. J. Lipid Res. 43, 5968.
  • Ross B. M., Moszczynska A., Erlich J. and Kish S. J. (1998) Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phos-pholipase A2 activity. J. Neurochem. 70, 786793.
  • Saunders R. D. and Horrocks L. A. (1984) Simultaneous extraction and preparation for high-performance liquid chromatography of prostaglandins and phospholipids. Anal. Biochem. 143, 7175.
  • Sebire G., Emilie D., Wallon C., Hery C., Devergne O., Delfraissy J. F., Galanaud P. and Tardieu M. (1993) In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J. Immunol. 150, 15171523.
  • Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J. and Griffin W. S. (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761766.
  • Shimizu T. and Wolfe L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 115.
  • Stephenson D. T., Manetta J. V., White D. L., Chiou X. G., Cox L., Gitter B., May P. C., Sharp J. D., Kramer R. M. and Clemens J. A. (1994) Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Res. 637, 97105.
  • Stephenson D. T., Lemere C. A., Selkoe D. J. and Clemens J. A. (1996) Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3, 5163.
  • Stewart W. F., Kawas C., Corrada M. and Metter E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626632.
  • Streit W. J. (1990) An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I–B4). J. Histo-chem. Cytochem. 38, 16831686.
  • Sun G. Y. and Hu Z. Y. (1995) Stimulation of phospholipase A2 expression in rat cultured astrocytes by LPS, TNF-α and IL-1β. Prog. Brain Res. 105, 231238.
  • Talbot K., Young R. A., Jolly-Tornetta C., Lee V. M., Trojanowski J. Q. and Wolf B. A. (2000) A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex. Neurochem. Int. 37, 1731.
  • Taniguchi Y., Yokoyama K., Inui K., Deguchi Y., Furukawa K. and Noda K. (1997) Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur. J. Pharmacol. 330, 221229.
  • Tong W., Hu Z. Y. and Sun G. Y. (1995) Stimulation of group II phospholipase A2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF-α and IL-1β. Interactive effects. Mol. Chem. Neuropathol. 25, 117.
  • Washizaki K., Smith Q. R., Rapoport S. I. and Purdon A. D. (1994) Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63, 727736.
  • Willard L. B., Hauss-Wegrzyniak B. and Wenk G. L. (1999) Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88, 193200.
  • Willard L. B., Hauss-Wegrzyniak B., DanysZ. W. and Wenk G. L. (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 134, 5865.
  • Yang H. C., Farooqui A. A. and Horrocks L. A. (1996) Plasmalogen-selective phospholipase A2 and its role in signal transduction. J. Lipid Med. Cell Signal 14, 913.
  • Yang H. C., Mosior M., Ni B. and Dennis E. A. (1999) Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J. Neurochem. 73, 12781287.